Dermata Therapeutics's market cap is currently $3.67M. The company's EPS TTM is $-1.66; its P/E ratio is ―; Dermata Therapeutics is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is $-1.59. See an overview of income statement, balance sheet, and cash flow financials.
